Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

A survey among dermatologists: diagnostics of superficial fungal infections – what is used and what is needed to initiate therapy and assess efficacy?

Saunte D. M. L., Piraccini B. M., Sergeev A. Y., Prohić A., Sigurgeirsson B., Rodríguez-Cerdeira C., Szepietowski J. C., Faergemann J., Arabatzis M., Pereiro M., Skerlev M., Lecerf P., Schmid-Grendelmeier P., Nenoff P., Nowicki R. J., Emtestam L., Hay R. J.
Journal of the European Academy of Dermatology and Venereology
Vol.33, Issue2, P. 421-427
Опубликовано: 2019
Тип ресурса: Статья

DOI:10.1111/jdv.15361

Аннотация:
Background: Superficial fungal infections are common. It is important to confirm the clinical diagnosis by mycological laboratory methods before initiating systemic antifungal treatment, especially as antifungal sensitivity and in vitro susceptibility may differ between different genera and species. For many years, the gold standard for diagnosis of superficial fungal infections has been direct fungal detection in the clinical specimen (microscopy) supplemented by culturing. Lately, newer molecular based methods for fungal identification have been developed. Objective: This study was initiated to focus on the current usage of mycological diagnostics for superficial fungal infections by dermatologists. It was designed to investigate whether it was necessary to differentiate between initial diagnostic tests and those used at treatment follow-up in specific superficial fungal infections. Methods: An online questionnaire was distributed among members of the EADV mycology Task Force and oth
Ключевые слова:
antifungal susceptibility; Article; candidiasis; clinical assessment; dermatologist; dermatophytosis; fungal viability; fungus culture; histology; human; Malassezia folliculitis; microscopy; molecular diagnosis; mycosis; onychomycosis; polymerase chain reaction; priority journal; tinea capitis; tinea versicolor; treatment response; advisory committee; clinical practice; dermatologist; dermatomycosis; microbial sensitivity test; microbiology; onychomycosis; questionnaire; risk assessment; treatment outcome; trends; antifungal agent; Advisory Committees; Antifungal Agents; Dermatologists; Dermatomycoses; Humans; Microbial Sensitivity Tests; Onychomycosis; Practice Patterns, Physicians'; Risk Assessment; Surveys and Questionnaires; Treatment Outcome
Язык текста: Английский
ISSN: 1468-3083
Saunte D. M. L.
Piraccini B. M.
Sergeev A. Y.
Prohić A.
Sigurgeirsson B.
Rodríguez-Cerdeira C.
Szepietowski J. C.
Faergemann J.
Arabatzis M.
Pereiro M.
Skerlev M.
Lecerf P.
Schmid-Grendelmeier P.
Nenoff P.
Nowicki R. J.
Emtestam L.
Hay R. J.
Саунте Д. М. Л.
Пираccини Б. М.
Сергеев А. Y.
Прохиć А.
Сигургеирссон Б.
Родрíгуез-Cердеира C.
Сзепиетоwски Й. C.
Фаергеманн Й.
Арабатзис М.
Переиро М.
Скерлев М.
Леcерф П.
Счмид-Гренделмеиер П.
Ненофф П.
Ноwиcки Р. Й.
Емтестам Л.
Хай Р. Й.
A survey among dermatologists: diagnostics of superficial fungal infections – what is used and what is needed to initiate therapy and assess efficacy?
Текст визуальный непосредственный
Journal of the European Academy of Dermatology and Venereology
John Wiley & Sons, Inc.
Vol.33, Issue2 P. 421-427
2019
Статья
antifungal susceptibility Article candidiasis clinical assessment dermatologist dermatophytosis fungal viability fungus culture histology human Malassezia folliculitis microscopy molecular diagnosis mycosis onychomycosis polymerase chain reaction priority journal tinea capitis tinea versicolor treatment response advisory committee clinical practice dermatologist dermatomycosis microbial sensitivity test microbiology onychomycosis questionnaire risk assessment treatment outcome trends antifungal agent Advisory Committees Antifungal Agents Dermatologists Dermatomycoses Humans Microbial Sensitivity Tests Onychomycosis Practice Patterns, Physicians' Risk Assessment Surveys and Questionnaires Treatment Outcome
Background: Superficial fungal infections are common. It is important to confirm the clinical diagnosis by mycological laboratory methods before initiating systemic antifungal treatment, especially as antifungal sensitivity and in vitro susceptibility may differ between different genera and species. For many years, the gold standard for diagnosis of superficial fungal infections has been direct fungal detection in the clinical specimen (microscopy) supplemented by culturing. Lately, newer molecular based methods for fungal identification have been developed. Objective: This study was initiated to focus on the current usage of mycological diagnostics for superficial fungal infections by dermatologists. It was designed to investigate whether it was necessary to differentiate between initial diagnostic tests and those used at treatment follow-up in specific superficial fungal infections. Methods: An online questionnaire was distributed among members of the EADV mycology Task Force and oth